Pieris Pharmaceuticals
Presence
Pieris Pharmaceuticals is a company listed under the stock ticker PIRS (US).
Executives
View the org chart displaying its 14 main executives
Most searched biographies at Pieris Pharmaceuticals
- Stephen Yoder, Director, President and Chief Executive Officer
- James Geraghty, Chairman of the Board
- Ann Barbier, Director
Create your alert
to follow the executive moves at Pieris Pharmaceuticals.
Pharmaceuticals
Pieris Pharmaceuticals has 1,862 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Pieris Pharmaceuticals
- Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential
- Pieris Pharmaceuticals Announces Milestone Achievement for Boston Pharmaceuticals' Initiation of Phase 1/2 Study of BOS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific
- Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring
- Jefferies Healthcare Conference
- Pieris Pharmaceuticals Announces AstraZeneca Discontinuation of Phase 2a Trial of Elarekibep (PRS-060/AZD1402) Due to New Non-Clinical Safety Findings From 13-week Toxicology Study
- Pieris Pharmaceuticals to Present at Jefferies 2023 Healthcare Conference
- Pieris Pharmaceuticals Announces Presentation of Encouraging Preclinical Data for PRS-400 at ATS 2023 International Conference
- Pieris Pharmaceuticals Announces Presentation of Promising Preclinical Data for PRS-220 at ATS 2023 International Conference
- Pieris Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Updates
- Pieris Pharmaceuticals Announces Successful Completion of Safety Review for 10 mg Dose of Phase 2a Trial of Elarekibep (PRS-060/AZD1402)
- View more press releases Close
Social media about Pieris Pharmaceuticals
- Pieris Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Pieris Pharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Stephen Yoder 
Call Pieris Pharmaceuticals at +1 857...
